A Revolutionary Stimulation Therapy for Newborns
Prapela is an affordable, noninvasive stimulation therapy that improves newborn health. For use in hospitals, our precise, stochastic stimulation naturally improves breathing and oxygenation, providing caregivers and parents with peace of mind.
Our past and present
Prapela was created in 2018 by John Konsin after being introduced to the unique technology created by Dr. David Paydarfar and further developed by a team of experienced medical professionals and engineers at Harvard's Wyss Institute for Biologically Inspired Engineering, The University of Massachusetts Medical School, and Massachusetts General Hospital. Since 1995, hundreds of newborns have experienced the benefits of our noninvasive therapy. As we prepare for clearance by the US Food & Drug Administration, our mission is to provide affordable solutions that improve the quality of life of newborns and their families. Click here to learn more about our team and Prapela.
One Technology, Many Uses
Our innovative technology is designed to provide a non-pharmacological solution to newborns with serious medical conditions. Click here to learn more about the clinical research behind our technology.
Apnea of Prematurity
What Healthcare Professionals Say About Prapela's Technology
"The role that mechanical stimulation plays in promoting regular breathing has been documented anecdotally but remained unquantified until now. Bloch-Salisbury et al. have taken an important step in demonstrating the role that controlled stochastic inputs can play in benefiting neonates, and we believe this holds great significance in promoting non-pharmacological intervention to improve neonatal outcomes."
Richard Martin, MD
Dept. of Pediatrics
Rainbow Babies & Children's Hospital
Editorial comment published in the Journal of Applied Physiology,
"Changing a mattress seemed like a small change but the benefits were quite large.
Parents kept asking if they could take it home."
Vincent Smith, MD
Division Chief of Newborn Medicine
Boston Medical Center
In the aftermath of the AOP Clinical Study at Beth Israel Deaconess Medical Center
"Creative strategies like this are really exciting, and I think the encouraging results are likely to be welcomed by families (who) often prefer minimal pharmacological treatment for young babies ."
Clare McCormack, PhD
Department of Child and Adolescent Psychiatry
NYU Grossman School of Medicine
Source: MedPage Today May 15, 2023 article "Vibrating Crib Mattress Eases Opioid Withdrawal for Exposed Infants"
"Repeated apneas can lead to low oxygen to vital organs and long-term neurodevelopmental issues. Caffeine was introduced over 20 years ago and there hasn't been anything new since. So we are excited to be working on a very promising solution with Prapela ."
Rachana, Singh, MD, MS
Associate Chief, Newborn Medicine
Tufts University School of Medicine